Literature DB >> 28147473

Endoscopic Findings of Gastric Extranodal Marginal Zone B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma.

Sang Kil Lee1.   

Abstract

Entities:  

Year:  2017        PMID: 28147473      PMCID: PMC5299986          DOI: 10.5946/ce.2017.014

Source DB:  PubMed          Journal:  Clin Endosc        ISSN: 2234-2400


× No keyword cloud information.
See "Correlation of Endoscopic Findings of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with Recurrence after Complete Remission" by Chang Min Lee, Dong Ho Lee, Byung Kyu Ahn, et al., on page 51-57. Approximately 360,000 new cases of non-Hodgkin’s lymphoma were diagnosed worldwide in 2014. Of these, approximately 7% were diagnosed with mucosa-associated lymphoid tissue (MALT) lymphoma [1]. Gastric extranodal marginal zone B-cell MALT lymphoma accounts for 1%–7% of malignant gastric tumors and 60%–75% of gastrointestinal MALT lymphomas [2]. Gastric MALT lymphoma shows various endoscopic findings. The structure and function of gastric MALT are similar to those of Peyer’s patches in the terminal ileum [3]. Gastric MALT originates in subepithelial layers, usually in the stromal space, and grows under the normal gastric foveolar glands [4]. Thus, both mucosal and submucosal lesions can be found on endoscopic examination. Therefore, the histologic diagnosis of lymphoma is often unexpected, even to an experienced endoscopist. Taal et al. attempted to classify the endoscopic findings in gastric MALT lymphoma into several categories [5]. Thereafter, several classification systems based on gross morphology were suggested [6,7]. However, there have been no generally accepted classification criteria, because the clinical implications of endoscopic categorization of gastric MALT lymphoma are still unclear. Advanced stage, gene translocation t(11;18) (q21;q21), and non-responder (no change) MALT lymphomas that persist after successful Helicobacter pylori eradication are associated with poor prognosis [8-10]. In addition to those factors, Lee et al. in this issue of Clinical Endoscopy, concluded that the endoscopically defined polypoid type is associated with poor prognosis, and is characterized by a longer duration to complete response (CR), with a higher likelihood of recurrence, compared to the endoscopically defined diffuse infiltration or ulceration types [11]. However, caution is needed when interpreting the results of this study. Even though the authors stated that there was no significant colinearity between endoscopic findings, Ann Arbor stage, and/or treatment, one of the three variables could be a potential confounding factor, as the authors suggested. With reference to their data summarized in the table, polypoid lesions are more likely to be diagnosed at an advanced Ann Arbor stage, as compared to diffuse infiltration or ulceration types. In a review of previous reports, Yokoi et al. suggested that the pathogenesis of polypoid gastric MALT lymphoma has little association with H. pylori infection [7]. However, the results of this study are different from those in Yokoi’s report. Thus, it is still uncertain whether there is a reasonable explanation for a causal relationship between polypoid gastric MALT lymphoma and poor prognosis. We hope that a follow-up study can demonstrate a correlation between polypoid MALT lymphoma and poor prognostic factors, such as nodal involvement [12] or plasmacytic differentiation [13]. Endoscopic ultrasonography (EUS) is essential for T-staging in gastric MALT lymphoma. EUS should be emphasized in the staging work-up for gastric MALT lymphoma. Recently, the European Society for Medical Oncology guideline for gastric MALT lymphoma recommended EUS to evaluate regional lymph nodes and gastric wall infiltration (level of evidence III, grade of recommendation A) [1]. Although this is a major limitation of a retrospective study, only about one-third of patients were examined by EUS. Nevertheless, it is interesting and commendable that the authors classified gastric MALT lymphoma using morphological categorization. As endoscopic devices are being developed, the description of endoscopic morphology of gastric lymphoma is now more detailed. A recent study focused on the diagnosis of gastric lymphoma based on endoscopic morphology [14]. Moreover, Nonaka et al. suggested that narrow-band imaging magnifying endoscopy may be useful not only in the diagnosis but also in the evaluation of the response to eradication therapy [15]. Nonetheless, there is insufficient evidence for an explanation of the distinct features of polypoid gastric MALT lymphoma. We do not know the causes of any morphological differences, but an ongoing study will resolve this question someday.
  15 in total

1.  Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  E Zucca; C Copie-Bergman; U Ricardi; C Thieblemont; M Raderer; M Ladetto
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

2.  [Endoscopic criteria for diagnosis of various macroscopic variants of non-Hodgkin's gastric lymphoma].

Authors:  O A Malikhova; B K Poddubnyĭ; I V Poddubnaia; O A Moskalenko; A Iu Kontsevaia
Journal:  Eksp Klin Gastroenterol       Date:  2010

3.  Is narrow-band imaging useful for histological evaluation of gastric mucosa-associated lymphoid tissue lymphoma after treatment?

Authors:  Kouichi Nonaka; Ken Ohata; Nobuyuki Matsuhashi; Michio Shimizu; Shin Arai; Yoshimitsu Hiejima; Hiroto Kita
Journal:  Dig Endosc       Date:  2013-09-30       Impact factor: 7.559

4.  Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis.

Authors:  T Radaszkiewicz; B Dragosics; P Bauer
Journal:  Gastroenterology       Date:  1992-05       Impact factor: 22.682

Review 5.  MALT lymphomas: pathogenesis can drive treatment.

Authors:  Francesco Bertoni; Bertrand Coiffier; Gilles Salles; Anastasios Stathis; Alexandra Traverse-Glehen; Catherine Thieblemont; Emanuele Zucca
Journal:  Oncology (Williston Park)       Date:  2011-11-15       Impact factor: 2.990

6.  Differences in endoscopic and clinicopathological features of primary and secondary gastric non-Hodgkin's lymphoma. German Gastrointestinal Lymphoma Study Group.

Authors:  M Kolve; W Fischbach; A Greiner; K Wilms
Journal:  Gastrointest Endosc       Date:  1999-03       Impact factor: 9.427

7.  The endoscopic spectrum of primary non-Hodgkin's lymphoma of the stomach.

Authors:  B G Taal; F C den Hartog Jager; G N Tytgat
Journal:  Endoscopy       Date:  1987-09       Impact factor: 10.093

Review 8.  Tertiary lymphoid organs in infection and autoimmunity.

Authors:  Katrijn Neyt; Frédéric Perros; Corine H GeurtsvanKessel; Hamida Hammad; Bart N Lambrecht
Journal:  Trends Immunol       Date:  2012-05-21       Impact factor: 16.687

9.  Stroma cell priming in enteric lymphoid organ morphogenesis.

Authors:  Manuela Ferreira; Rita G Domingues; Henrique Veiga-Fernandes
Journal:  Front Immunol       Date:  2012-07-24       Impact factor: 7.561

10.  Correlation of Endoscopic Findings of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with Recurrence after Complete Remission.

Authors:  Chang Min Lee; Dong Ho Lee; Byung Kyu Ahn; Jae Jin Hwang; Hyuk Yoon; Young Soo Park; Cheol Min Shin; Nayoung Kim
Journal:  Clin Endosc       Date:  2016-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.